Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2018-11-13 Regulatory Filings
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
107年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment information related to investments in mainland China by a Taiwanese listed company, including capital amounts, investment methods, and regulatory limits. It includes notes explaining the investment methods and accounting treatments. The document is relatively short (1278 characters) and does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure specific to cross-strait investment reporting requirements rather than a full financial report or earnings release. There is no indication that this is an announcement of a report publication or a certification. Given the nature of the content and the lack of fit with other categories, this document best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-11-13 Chinese
107年第3季財務報告書 — 201804_4142_AI3.pdf
Regulatory Filings
2018-11-13 Chinese
107年第3季財務報告書 — 201804_4142_AI1.pdf
Regulatory Filings
2018-11-13 Chinese
107年第3季財務報告書 — 201803_4142_AI1.pdf
Regulatory Filings
2018-11-13 Chinese
107年第3季財務報告書 — 201802_4142_AI1.pdf
Regulatory Filings
2018-11-13 Chinese
107年第3季財務報告書 — 201801_4142_AI1.pdf
Regulatory Filings
2018-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.